OpenAlex
PricingAboutJobs
Log inGet started
Work

Exploratory biomarker analysis of ribociclib plus letrozole in recurrent low-grade serous carcinoma: A GOG-3026 correlative study.

PubMed

Year: 2026
Type: article
Source: PubMed
DOI: 10.1016/j.ygyno.2026.11.003
Authors: Kwong-Kwok Wong, Wei Deng, Yvonne T M Tsang, S John Weroha, Hye Sook Chon, Vivek Podder, Floor Backes, Eric Thomas, Meaghan Elizabeth Tenney, Shannon N Westin, Merry J Markham, Robert L Coleman, Thomas J Herzog, David M Gershenson, Brian M Slomovitz
Institutions: The University of Texas MD Anderson Cancer Center, Roswell Park Comprehensive Cancer Center, Mayo Clinic, Moffitt Cancer Center, Mount Sinai Medical Center, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Oklahoma Cancer Specialists and Research Institute, Northside Hospital, The US Oncology Network, University of Cincinnati
Language: English

Topic: Ovarian cancer diagnosis and treatment
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: ribociclib, letrozole, CDK4/6 inhibitors, biomarkers, Ki-67, p16, MAPK pathway alterations, FANCD2, BRAF, KRAS, NRAS, progression-free survival, objective response rate
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W7233419449
FWCI:
Cites:
Cited by:
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms